OnKure Therapeutics Ownership | Who Owns OnKure Therapeutics?

OnKure Therapeutics Ownership Summary

OnKure Therapeutics is owned by 25.69% institutional investors, 10.48% insiders, and 63.84% retail investors. Ra capital management is the largest institutional shareholder, holding 29.58% of OKUR shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.85% of its assets in OnKure Therapeutics shares.

OKUR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	OnKure Therapeutics	25.69%	10.48%	63.84%
Sector	Healthcare Stocks	50.51%	12.37%	37.12%
Industry	Biotech Stocks	48.95%	12.07%	38.98%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	4.00M	29.58%	$16.55M
Acorn capital advisors	2.84M	21.01%	$11.76M
Stepstone group lp	2.66M	19.68%	$11.01M
Prosight management, lp	2.15M	15.94%	$8.92M
Bvf inc/il	1.98M	14.64%	$8.19M
Vivo capital	1.93M	14.26%	$7.98M
Vestal point capital, lp	1.84M	13.61%	$7.62M
Adage capital partners gp	1.20M	8.91%	$4.99M
Sio capital management	1.08M	7.98%	$4.47M
Vanguard group	626.59K	4.64%	$1.82M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Stepstone group lp	2.66M	5.31%	$11.01M
Acorn capital advisors	2.84M	3.34%	$11.76M
Prosight management, lp	2.15M	1.46%	$8.92M
Rosalind advisors	443.76K	0.74%	$1.84M
Vivo capital	1.93M	0.67%	$7.98M
Sio capital management	1.08M	0.64%	$4.47M
Rangeley capital	95.00K	0.38%	$393.30K
Bvf inc/il	1.98M	0.26%	$8.19M
Stonepine capital management	132.58K	0.22%	$548.87K
Vestal point capital, lp	1.84M	0.21%	$7.62M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	4.00M	0.18%	4.00M
Stepstone group lp	2.66M	5.31%	2.17M
Bvf inc/il	1.98M	0.26%	1.98M
Vivo capital	1.93M	0.67%	1.93M
Prosight management, lp	2.15M	1.46%	1.34M

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-1.84M
Foresite capital management vi	-	-	-1.45M
Perceptive advisors	-	-	-1.00M
Samsara biocapital	-	-	-824.15K
Shay capital	132.22K	0.05%	-648.64K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	4.00M	0.18%	4.00M	$16.55M
Bvf inc/il	1.98M	0.26%	1.98M	$8.19M
Vivo capital	1.93M	0.67%	1.93M	$7.98M
Adage capital partners gp	1.20M	0.01%	1.20M	$4.99M
Sio capital management	1.08M	0.64%	1.08M	$4.47M

Sold Out

Holder	Change
Northwestern mutual wealth management	-2.00
Mai capital management	-6.00
Group one trading	-56.00
Gf fund management	-271.00
Fmr	-400.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	22	-47.62%	3,471,972	-68.59%	25	0.38%	11	-35.29%	6	-57.14%
Dec 31, 2025	26	-38.10%	6,391,960	-37.45%	47	0.83%	12	-29.41%	10	-16.67%
Sep 30, 2025	42	-8.70%	10,219,608	5.81%	75	1.48%	17	-19.05%	12	-7.69%
Jun 30, 2025	48	4.35%	10,776,588	-9.78%	79	1.01%	23	-50.00%	13	-
Mar 31, 2025	2	-	710,559	-	5	-	2	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard MStar Total Stk Mkt Idx Invest	1.15M	2.85%	44.25K
Vanguard Morn Total Stk Mkt Idx Investor	1.11M	2.75%	599.66K
Vanguard Total Stock Mkt Idx Inv	1.11M	2.75%	599.66K
iShares Russell 2000 ETF	556.71K	1.37%	-9.89K
Vanguard Institutional Extnd Mkt Idx Tr	305.73K	0.75%	3.30K
iShares Russell 2000 Value ETF	224.17K	0.55%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	150.00K	0.37%	-
Vanguard Russell 2000 ETF	147.89K	0.37%	-3.64K
Russell 2000 Equity Index Fund B	143.64K	0.36%	143.64K
Russell 2000 Index Non-Lendable Fund	143.64K	0.36%	143.64K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 22, 2026	Saccomano Nicholas A	President and CEO	Sell	$378.08
Jun 22, 2026	Leverone Jason A.	Chief Financial Officer	Sell	$1.33K
Mar 23, 2026	Saccomano Nicholas A	President and CEO	Sell	$357.46
Mar 23, 2026	Leverone Jason A.	Chief Financial Officer	Sell	$1.25K
Dec 22, 2025	Saccomano Nicholas A	President and CEO	Sell	$258.19

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	2
2026 Q1	-	2
2025 Q4	-	2
2025 Q3	-	2
2025 Q2	2	8

OKUR Ownership FAQ

Who Owns OnKure Therapeutics?

OnKure Therapeutics shareholders are primarily institutional investors at 25.69%, followed by 10.48% insiders and 63.83% retail investors. The average institutional ownership in OnKure Therapeutics's industry, Biotech Stocks , is 48.95%, which OnKure Therapeutics falls below.

Who owns the most shares of OnKure Therapeutics?

OnKure Therapeutics’s largest shareholders are Ra capital management (4M shares, 29.58%), Acorn capital advisors (2.84M shares, 21.01%), and Stepstone group lp (2.66M shares, 19.68%). Together, they hold 70.28% of OnKure Therapeutics’s total shares outstanding.

Does Blackrock own OnKure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of OnKure Therapeutics.

Who is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested?

Stepstone group lp is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.31% of its assets in 2.66M OnKure Therapeutics shares, valued at 11.01M$.

Who is the top mutual fund holder of OnKure Therapeutics shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of OnKure Therapeutics shares, with 2.85% of its total shares outstanding invested in 1.15M OnKure Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools